Breast Nodules FAQ
Breast Nodules FAQ
The questions on this page are the ones patients ask once the clinical ones are settled: what will this cost, how long do I need to be here, what should I send before I come, and what happens after I go home. The honest answers share one feature — they depend on what the nodule turns out to be, because an assessment that ends in a benign conclusion and one that needs a procedure are different amounts of everything. That is why the useful answer on cost is an itemised estimate rather than a number, and why the useful answer on travel is a range with a defined decision point in the middle. This page sets out how each of those practicalities works in practice, so that the arrangements can be made around the assessment rather than in the dark.
What it costs, and why the honest answer starts with the answer
Anyone quoting a single figure before an assessment is guessing, and the reason is worth stating plainly:
- An assessment has a price; a treatment has several. The assessment — examination, ultrasound, mammography where indicated, and a needle biopsy if needed — is a defined and usually modest set of items. What follows depends entirely on the result: most patients need nothing further, some need an aspiration or a small excision, and a minority need referral into the breast cancer pathway with a very different set of costs.
- What an estimate contains — the itemised list of what is planned, the fee for each, and the decision points at which the plan — and therefore the cost — can change. A credible estimate names the point at which it stops predicting.
- Where the value sits — in doing the sequence correctly and in one visit: an assessment that is completed properly the first time avoids the slow accumulation of repeated appointments, repeated scans and repeated travel that a fragmented pathway produces.
- What is never quoted — outcome rates or promises. Cost is a legitimate question with an answer; reassurance about outcomes has to come from the findings, not from a price list.
Ask for the estimate in writing, with the items named, and ask what would change it. That is a fair request, and the answer should be an itemised plan rather than a package.
How long you need to be here
The duration depends on which of three tracks the visit follows, and the tracks diverge only after the first steps:
- Assessment, benign conclusion — examination, imaging and, where needed, a needle biopsy can usually be completed within one short visit. Where no procedure follows, the stay is measured in days, and the plan is written before departure.
- Assessment plus a procedure — a cyst aspiration is a clinic procedure taking minutes, adding nothing to the stay; an excision is day-case surgery, after which a few days locally before flying home is the usual advice.
- A result that changes the plan — if a biopsy returns a serious answer, the stay is re-planned around staging and the multidisciplinary discussion, and the international desk coordinates that change with the patient rather than around them.
- Pathology time is the one fixed quantity — tissue needs days to be processed and reported properly. Nothing sensible shortens it, which is why the realistic plan builds in the wait rather than promising an instant answer.
The practical advice: plan the trip around the assessment plus the pathology interval, and hold the return booking loosely enough that a change of plan does not cost a second journey.
What to send before you come
Records sent in advance convert the first appointment from a reconstruction into a decision. The list is specific:
- The imaging images, not only the reports — the mammogram and ultrasound studies themselves, on disc or by secure transfer, with the reports. Images allow an independent read and comparison; a report alone often cannot.
- Any previous biopsy pathology — the slides or the full report of any earlier biopsy, including benign ones. A documented previous result changes how a new finding is interpreted.
- Anything you know about your own history — when the lump appeared, whether it changes with the cycle, what hormone therapy or contraception you take, pregnancies and breastfeeding, and any family history of breast or ovarian cancer with ages where known.
- Previous imaging from more than a year or two ago — even old films are useful, because the most reassuring finding in breast imaging is a lump that looked exactly the same years ago.
If some of this is hard to assemble, send what you have — a review of incomplete records can say what is missing and what it would change, which is itself a useful answer before travelling.
Insurance, direct billing and self-pay
Funding a visit from abroad has three routes, and being clear about which applies makes the rest straightforward:
- Direct billing — for insurers and assistance companies with an agreement in place, the hospital bills them directly for the covered items and the patient handles only what is not covered. Confirming the agreement before travel is the step that prevents most surprises.
- Self-pay with a written estimate — where there is no agreement, or for items an insurer excludes, an itemised estimate is provided in advance and settled at the point of care. An international desk can produce the documentation an insurer needs for reimbursement.
- Mixed arrangements — the commonest pattern in practice: the assessment covered, a procedure needing pre-authorisation, some items paid directly. Knowing which items sit in which category before arrival is what the estimate is for.
The practical request: send your insurance details when you send your records, so the coverage question is answered alongside the clinical one rather than at the payment desk.
After you go home
Follow-up is planned, not improvised, and almost all of it can be done from a distance:
- The pathology discussion — where a biopsy was taken, the result and its implications are discussed by video or by a written report if the patient has already travelled home, with the documents needed for local onward care provided.
- The imaging schedule — the interval set by what was found is written down explicitly, together with what each review is checking, so that a local clinician can carry it out and compare against the baseline images.
- Wound care — after an excision, a local provider or a video check handles the routine wound review; the parts that need this hospital are the pathology result and any change in the plan.
- A named point of contact — the international desk stays the route back for questions and for arranging any further visit, so that returning home does not mean the file closing.
What patients value most about this arrangement is having the follow-up schedule in writing before they leave: a document with dates and purposes turns uncertainty about the future into a plan.
Travelling with someone
A breast assessment sits in the small category of appointments where most patients would rather not be alone, and planning for a companion is worthwhile:
- The waiting is the part that matters — imaging is quick and results are discussed in a room; having someone to sit with between those two moments is the main reason patients travel accompanied.
- Two people hear more — the appointment where findings are explained contains a great deal of specific information, and a second person taking notes reliably improves what is remembered afterwards.
- After a procedure — after a needle biopsy or a small excision a companion is useful for the practicalities of getting back, and some units ask that a patient not drive after sedation.
- Practical arrangements — accommodation near the hospital, interpreting support where needed, and paperwork for a companion’s visa are all handled by the international desk when the request is made in advance.
There is no clinical reason a companion is required for most breast assessment visits. The reason to bring one is simpler, and it is a good enough reason on its own.